杨桥, 李禄生. 颅内生殖细胞肿瘤的治疗进展[J]. 中国肿瘤临床, 2020, 47(11): 590-594. DOI: 10.3969/j.issn.1000-8179.2020.11.483
引用本文: 杨桥, 李禄生. 颅内生殖细胞肿瘤的治疗进展[J]. 中国肿瘤临床, 2020, 47(11): 590-594. DOI: 10.3969/j.issn.1000-8179.2020.11.483
Yang Qiao, Li Lusheng. Progress in the treatment of intracranial germ cell tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(11): 590-594. DOI: 10.3969/j.issn.1000-8179.2020.11.483
Citation: Yang Qiao, Li Lusheng. Progress in the treatment of intracranial germ cell tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(11): 590-594. DOI: 10.3969/j.issn.1000-8179.2020.11.483

颅内生殖细胞肿瘤的治疗进展

Progress in the treatment of intracranial germ cell tumors

  • 摘要: 颅内生殖细胞肿瘤(intracranial germ cell tumors,ICGCTs)是一种少见的颅内胚胎性肿瘤,具有多种组织学类型。大多数类型的生殖细胞肿瘤对放化疗敏感,早期治疗可治愈,5年总生存率(overall survival rate,OSR)可达90%,其他恶性非生殖细胞瘤性生殖细胞肿瘤(non-germinomatous germ cell tumors,NGGCTs)的5年OSR低于70%。近年,随着外科学、影像学、核医学、药学等相关学科的发展,IGGCTs的总体治疗效果有了长足的进展,然而囿于病理基因等方面研究进展缓慢,治疗方案并不统一,缺乏规范化和明确的临床路径和诊治指南。本文就ICGCTs的治疗经验和进展进行综述,以期为临床治疗提供新的思路。

     

    Abstract: Intracranial germ cell tumors (IGGCTs) are rare intracranial embryonal tumors with various histological types. Most types of germ cell tumors are sensitive to radiotherapy and chemotherapy and can be cured with early treatment. The 5-year overall survival rate (OSR) of people with IGGCT has been reported as high as 90%, while the 5-year OSR of other malignant non-germinomatous germ cell tumors (NGGCTs) has been reported as less than 70%. Due to developments in surgery, imaging, nuclear medicine, pharmaceuticals, and other disciplines, the therapeutic effect of IGGCTs has improved in the last decade. However, due to the slow progress in researching its pathological genes, a treatment plan has not been standardized, and there is no standardized and clear clinical pathway or diagnosis and treatment guide. Here, the treatment experience and progress of IGGCTs is reviewed.

     

/

返回文章
返回